Hostname: page-component-7b7567c8c-8p88z Total loading time: 0 Render date: 2026-11-19T21:30:41.969Z Has data issue: false hasContentIssue false

Pituitary Carcinoma with Subependymal Spread

Published online by Cambridge University Press:  02 December 2014

Krishna Kumar*
Affiliation:
Section of Neurosurgery, Department of Surgery, Regina General Hospital, University of Saskatchewan, Regina, Saskatchewan, Canada
Jefferson R. Wilson
Affiliation:
Section of Neurosurgery, Department of Surgery, Regina General Hospital, University of Saskatchewan, Regina, Saskatchewan, Canada
Qiuyan Li
Affiliation:
Department of Pathology, Regina General Hospital, University of Saskatchewan, Regina, Saskatchewan, Canada
Ryan Phillipson
Affiliation:
Department of Radiology, Regina General Hospital, University of Saskatchewan, Regina, Saskatchewan, Canada
*
Regina General Hospital, Medical Office Wing, 1440 14th Avenue, Regina, Saskatchewan, S4P 0W5, Canada
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Pituitary carcinomas have been reported to metastasize systemically and, less commonly, along the craniospinal axis. Metastatic lesions have been reported in the cerebral cortex, cerebellum, spinal cord, leptomeninges, cervical lymph nodes, liver, ovaries, and bone. The authors are unaware of any other examples of subependymal metastases of a pituitary carcinoma. We report such a case.

Pituitary carcinoma is rare, accounting for roughly 0.2%1,3-5 of all pituitary tumors, with approximately 140 cases reported in the literature. These tumors are associated with a very high mortality, with 66% of patients dying within the first year after diagnosis. Pituitary carcinomas are differentiated from invasive pituitary adenomas by the presence of non-contiguous craniospinal tumor deposits and/or distant systemic metastases. The majority (88%) of these carcinomas prove to be hormone secreting, with prolactin secreting tumors being the most common. Invasive carcinomas evolve from hormone secreting pituitary adenomas after a latency period. Pituitary carcinomas have a predilection for systemic spread. The rate of systemic metastasis approaches 71% for prolactin producing tumors and 57% for ACTH producing tumors. Thirteen percent of tumors demonstrate both systemic and craniospinal patterns of metastatic spread.

Information

Type
Peer Reviewed Letter
Copyright
Copyright © The Canadian Journal of Neurological 2006